Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 49 | 2025 | 1255 | 10.800 |
Why?
|
| Gait | 15 | 2024 | 822 | 3.690 |
Why?
|
| Knee Joint | 25 | 2024 | 1685 | 3.330 |
Why?
|
| Quadriceps Muscle | 6 | 2024 | 157 | 2.930 |
Why?
|
| Walking | 12 | 2024 | 1201 | 2.220 |
Why?
|
| Cartilage, Articular | 12 | 2025 | 1104 | 1.970 |
Why?
|
| Patellofemoral Joint | 4 | 2018 | 133 | 1.890 |
Why?
|
| Muscle Strength | 8 | 2022 | 641 | 1.830 |
Why?
|
| Chondrocytes | 11 | 2025 | 800 | 1.370 |
Why?
|
| Weight-Bearing | 4 | 2020 | 534 | 1.270 |
Why?
|
| Low Back Pain | 4 | 2021 | 990 | 1.200 |
Why?
|
| Exercise Therapy | 4 | 2024 | 939 | 1.000 |
Why?
|
| Arthralgia | 3 | 2019 | 459 | 0.990 |
Why?
|
| Menisci, Tibial | 4 | 2015 | 267 | 0.970 |
Why?
|
| Pain | 12 | 2023 | 5100 | 0.840 |
Why?
|
| Movement | 2 | 2020 | 1490 | 0.790 |
Why?
|
| Range of Motion, Articular | 11 | 2024 | 1599 | 0.770 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2020 | 170 | 0.720 |
Why?
|
| Foot | 3 | 2018 | 577 | 0.670 |
Why?
|
| X-Ray Microtomography | 7 | 2018 | 457 | 0.660 |
Why?
|
| Bone Malalignment | 3 | 2018 | 38 | 0.660 |
Why?
|
| Rats, Wistar | 13 | 2018 | 1890 | 0.660 |
Why?
|
| Exercise Test | 4 | 2020 | 2187 | 0.620 |
Why?
|
| Physical Conditioning, Animal | 3 | 2016 | 363 | 0.600 |
Why?
|
| Cross-Sectional Studies | 25 | 2022 | 26395 | 0.580 |
Why?
|
| Disability Evaluation | 5 | 2018 | 1839 | 0.580 |
Why?
|
| Posture | 3 | 2018 | 957 | 0.580 |
Why?
|
| Osteoarthritis | 4 | 2023 | 1070 | 0.570 |
Why?
|
| Collagen Type II | 8 | 2023 | 151 | 0.560 |
Why?
|
| Muscle Weakness | 1 | 2020 | 413 | 0.550 |
Why?
|
| Sarcopenia | 1 | 2021 | 377 | 0.540 |
Why?
|
| Actigraphy | 2 | 2019 | 527 | 0.540 |
Why?
|
| Flatfoot | 1 | 2017 | 60 | 0.530 |
Why?
|
| Activities of Daily Living | 10 | 2022 | 2434 | 0.470 |
Why?
|
| Porosity | 1 | 2015 | 352 | 0.470 |
Why?
|
| Tibia | 3 | 2017 | 1076 | 0.470 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2016 | 847 | 0.460 |
Why?
|
| Cartilage Diseases | 3 | 2023 | 160 | 0.420 |
Why?
|
| Electric Stimulation | 1 | 2018 | 1742 | 0.420 |
Why?
|
| Accidental Falls | 1 | 2021 | 1080 | 0.420 |
Why?
|
| Japan | 6 | 2021 | 1418 | 0.400 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1798 | 0.400 |
Why?
|
| Radiography | 9 | 2022 | 6991 | 0.390 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 637 | 0.390 |
Why?
|
| Aged | 34 | 2024 | 171786 | 0.390 |
Why?
|
| Pain Measurement | 9 | 2019 | 3586 | 0.380 |
Why?
|
| Male | 52 | 2025 | 365203 | 0.370 |
Why?
|
| Extracellular Matrix | 4 | 2025 | 1739 | 0.360 |
Why?
|
| Aged, 80 and over | 17 | 2021 | 59739 | 0.360 |
Why?
|
| Cartilage | 3 | 2023 | 811 | 0.360 |
Why?
|
| Knee Injuries | 1 | 2015 | 495 | 0.350 |
Why?
|
| Muscle, Skeletal | 5 | 2023 | 4978 | 0.350 |
Why?
|
| Osteophyte | 2 | 2022 | 44 | 0.320 |
Why?
|
| Middle Aged | 35 | 2024 | 223737 | 0.320 |
Why?
|
| Disabled Persons | 1 | 2018 | 1210 | 0.310 |
Why?
|
| Female | 44 | 2025 | 397515 | 0.300 |
Why?
|
| Severity of Illness Index | 10 | 2021 | 15951 | 0.290 |
Why?
|
| Hip Joint | 3 | 2019 | 1018 | 0.290 |
Why?
|
| Muscular Atrophy | 3 | 2015 | 335 | 0.290 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2015 | 945 | 0.290 |
Why?
|
| Rats | 13 | 2018 | 23786 | 0.280 |
Why?
|
| Humans | 59 | 2025 | 768970 | 0.260 |
Why?
|
| Exercise | 3 | 2018 | 5954 | 0.260 |
Why?
|
| Collagen | 5 | 2015 | 2646 | 0.230 |
Why?
|
| Locomotion | 2 | 2018 | 388 | 0.230 |
Why?
|
| Immobilization | 2 | 2016 | 229 | 0.230 |
Why?
|
| Oncostatin M | 1 | 2023 | 42 | 0.220 |
Why?
|
| Kinetics | 3 | 2020 | 6332 | 0.210 |
Why?
|
| Complement C4b | 1 | 2023 | 124 | 0.210 |
Why?
|
| Sprains and Strains | 1 | 2023 | 76 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2018 | 2990 | 0.190 |
Why?
|
| Aggrecans | 2 | 2019 | 89 | 0.190 |
Why?
|
| Animals | 24 | 2025 | 169335 | 0.190 |
Why?
|
| Isometric Contraction | 1 | 2022 | 150 | 0.190 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2016 | 507 | 0.180 |
Why?
|
| Progesterone | 1 | 2025 | 752 | 0.180 |
Why?
|
| Knee | 2 | 2019 | 278 | 0.170 |
Why?
|
| Femur | 2 | 2017 | 1321 | 0.170 |
Why?
|
| Platelet-Rich Plasma | 1 | 2022 | 180 | 0.170 |
Why?
|
| Calcaneus | 2 | 2018 | 144 | 0.170 |
Why?
|
| Lasers | 2 | 2021 | 952 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 243 | 0.160 |
Why?
|
| Algorithms | 1 | 2020 | 14201 | 0.160 |
Why?
|
| Tendons | 1 | 2023 | 557 | 0.160 |
Why?
|
| Hallux Valgus | 1 | 2020 | 67 | 0.160 |
Why?
|
| Physical Therapy Modalities | 2 | 2023 | 533 | 0.160 |
Why?
|
| Braces | 1 | 2020 | 139 | 0.160 |
Why?
|
| Spinal Cord Diseases | 1 | 2021 | 293 | 0.160 |
Why?
|
| Metatarsal Bones | 1 | 2020 | 111 | 0.160 |
Why?
|
| Sacroiliac Joint | 1 | 2019 | 59 | 0.160 |
Why?
|
| Ankle Injuries | 1 | 2023 | 339 | 0.150 |
Why?
|
| Hip | 1 | 2020 | 256 | 0.150 |
Why?
|
| Collagen Type I | 2 | 2019 | 620 | 0.150 |
Why?
|
| Sciatic Neuropathy | 1 | 2018 | 76 | 0.150 |
Why?
|
| Mechanical Phenomena | 1 | 2019 | 143 | 0.150 |
Why?
|
| Torque | 1 | 2018 | 133 | 0.150 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 18354 | 0.140 |
Why?
|
| Cell Culture Techniques | 2 | 2015 | 1667 | 0.140 |
Why?
|
| Estradiol | 1 | 2025 | 1952 | 0.140 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2016 | 48 | 0.140 |
Why?
|
| Smad5 Protein | 1 | 2016 | 26 | 0.140 |
Why?
|
| Femur Head | 1 | 2019 | 297 | 0.140 |
Why?
|
| Menopause | 1 | 2025 | 1656 | 0.130 |
Why?
|
| Pelvic Bones | 1 | 2019 | 274 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2016 | 58 | 0.130 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2016 | 72 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 163 | 0.130 |
Why?
|
| Logistic Models | 5 | 2019 | 13318 | 0.130 |
Why?
|
| Pressure | 1 | 2019 | 1172 | 0.130 |
Why?
|
| Catastrophization | 1 | 2019 | 352 | 0.130 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 1500 | 0.130 |
Why?
|
| Athletic Performance | 1 | 2017 | 113 | 0.130 |
Why?
|
| Hypergravity | 1 | 2015 | 5 | 0.130 |
Why?
|
| Microtechnology | 1 | 2015 | 70 | 0.120 |
Why?
|
| Joint Instability | 1 | 2023 | 803 | 0.120 |
Why?
|
| Acid Phosphatase | 1 | 2015 | 141 | 0.120 |
Why?
|
| Weightlessness Simulation | 1 | 2015 | 41 | 0.120 |
Why?
|
| Video Recording | 2 | 2017 | 976 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 344 | 0.120 |
Why?
|
| Social Participation | 1 | 2017 | 187 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2018 | 409 | 0.120 |
Why?
|
| Sciatic Nerve | 1 | 2018 | 628 | 0.120 |
Why?
|
| Risk Factors | 5 | 2021 | 74976 | 0.120 |
Why?
|
| Ultrasonic Therapy | 1 | 2016 | 217 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12095 | 0.120 |
Why?
|
| Radius Fractures | 1 | 2020 | 515 | 0.120 |
Why?
|
| Weightlessness | 1 | 2015 | 103 | 0.110 |
Why?
|
| Autophagy | 1 | 2022 | 1351 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 2974 | 0.110 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2014 | 101 | 0.110 |
Why?
|
| Collagen Type III | 1 | 2014 | 92 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 612 | 0.110 |
Why?
|
| Independent Living | 1 | 2018 | 584 | 0.110 |
Why?
|
| Collagen Type IV | 1 | 2014 | 125 | 0.110 |
Why?
|
| Collagenases | 1 | 2014 | 221 | 0.110 |
Why?
|
| Osteocytes | 1 | 2015 | 193 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2016 | 9684 | 0.110 |
Why?
|
| Temperature | 3 | 2015 | 2235 | 0.110 |
Why?
|
| Injections, Intra-Articular | 3 | 2022 | 288 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11116 | 0.110 |
Why?
|
| Body Water | 1 | 2014 | 340 | 0.100 |
Why?
|
| Bone Diseases | 1 | 2016 | 416 | 0.100 |
Why?
|
| Self Report | 3 | 2018 | 3773 | 0.100 |
Why?
|
| Joints | 1 | 2014 | 324 | 0.100 |
Why?
|
| Procollagen | 1 | 2013 | 189 | 0.100 |
Why?
|
| Comorbidity | 2 | 2018 | 10592 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2019 | 1441 | 0.100 |
Why?
|
| Bone Transplantation | 1 | 2017 | 925 | 0.100 |
Why?
|
| Phenotype | 2 | 2023 | 16731 | 0.100 |
Why?
|
| Recurrence | 2 | 2023 | 8513 | 0.100 |
Why?
|
| Contracture | 1 | 2014 | 236 | 0.100 |
Why?
|
| ROC Curve | 1 | 2019 | 3629 | 0.090 |
Why?
|
| Time Factors | 6 | 2021 | 40261 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2014 | 809 | 0.090 |
Why?
|
| Cysts | 1 | 2016 | 685 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2020 | 6002 | 0.090 |
Why?
|
| Sex Factors | 1 | 2024 | 10633 | 0.090 |
Why?
|
| Lower Extremity | 1 | 2018 | 1217 | 0.090 |
Why?
|
| Swine | 3 | 2014 | 5997 | 0.080 |
Why?
|
| Cell Death | 1 | 2015 | 1682 | 0.080 |
Why?
|
| Mice | 4 | 2025 | 82072 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3836 | 0.080 |
Why?
|
| Aging | 3 | 2023 | 8745 | 0.080 |
Why?
|
| Hindlimb | 3 | 2015 | 516 | 0.080 |
Why?
|
| Glycosaminoglycans | 3 | 2015 | 611 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1794 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 20245 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2017 | 1405 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 22379 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 1672 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2019 | 6346 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 4076 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2018 | 1586 | 0.060 |
Why?
|
| Muscle Contraction | 2 | 2023 | 1209 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10868 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14752 | 0.060 |
Why?
|
| Prevalence | 1 | 2021 | 15879 | 0.060 |
Why?
|
| Health Status | 1 | 2017 | 4095 | 0.050 |
Why?
|
| Mental Health | 1 | 2018 | 3275 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2019 | 19023 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3518 | 0.050 |
Why?
|
| Proteins | 1 | 2016 | 6011 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7453 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2021 | 143 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5151 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12806 | 0.040 |
Why?
|
| Prognosis | 2 | 2023 | 30046 | 0.040 |
Why?
|
| Ankle | 1 | 2023 | 353 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2023 | 553 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 24333 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2022 | 23653 | 0.040 |
Why?
|
| Apoptosis | 1 | 2015 | 9527 | 0.040 |
Why?
|
| Depression | 1 | 2018 | 8231 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 825 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1136 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39394 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11684 | 0.040 |
Why?
|
| Postural Balance | 1 | 2021 | 639 | 0.030 |
Why?
|
| Body Weight | 2 | 2019 | 4628 | 0.030 |
Why?
|
| Estrogens | 1 | 2023 | 1536 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 54962 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2015 | 48 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2015 | 79 | 0.030 |
Why?
|
| Centrifugation | 1 | 2015 | 122 | 0.030 |
Why?
|
| Azo Compounds | 1 | 2015 | 116 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2015 | 194 | 0.030 |
Why?
|
| Hindlimb Suspension | 1 | 2015 | 76 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 371 | 0.030 |
Why?
|
| Quality of Life | 1 | 2016 | 13510 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2015 | 124 | 0.030 |
Why?
|
| Restraint, Physical | 1 | 2015 | 185 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 223851 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 1232 | 0.030 |
Why?
|
| Surface Properties | 1 | 2015 | 1169 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2018 | 799 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2126 | 0.020 |
Why?
|
| Cell Count | 1 | 2016 | 1833 | 0.020 |
Why?
|
| Home Care Services | 1 | 2018 | 660 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2474 | 0.020 |
Why?
|
| Postmenopause | 1 | 2020 | 2519 | 0.020 |
Why?
|
| DNA | 2 | 2015 | 7214 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2018 | 13055 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2827 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2016 | 1295 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 2862 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81903 | 0.020 |
Why?
|
| Disease Progression | 2 | 2018 | 13674 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 2714 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3530 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4592 | 0.020 |
Why?
|
| Pregnancy | 2 | 2019 | 30265 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8559 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12430 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14794 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22296 | 0.010 |
Why?
|
| Gene Expression | 1 | 2015 | 7603 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7609 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 60131 | 0.010 |
Why?
|
Concepts
(238)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_